Praxis director receives RSU and option grants
Praxis Precision Medicines director Jill DeSimone received new equity awards as part of her compensation.
Rhea-AI Filing Summary
Praxis Precision Medicines director Jill DeSimone received new equity awards as part of her compensation. She was granted 1,371 restricted stock units, each representing a right to receive one share of common stock, vesting in a single installment on the earlier of June 10, 2027 or the company’s 2027 annual stockholders meeting.
She also received a stock option for 648 shares of common stock at an exercise price of $240.66 per share, vesting in twelve equal monthly installments beginning July 10, 2026 and ending on the earlier of June 10, 2027 or the 2027 annual meeting. After these grants, she directly holds 2,337 shares of common stock and 648 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 2,019 shares
Grant/Award
2 txns
Insider
DeSimone Jill
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 648 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,371 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 648 contracts (Direct);
Common Stock — 2,337 shares (Direct)
Footnotes (2)
- F1. Ms. DeSimone was awarded 1,371 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in a single annual installment on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders. The restricted stock units may be settled only by delivering shares of the Issuer's common stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- F2. The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month, with the first such installment occurring on July 10, 2026 and the final such installment occurring on the earlier of (i) June 10, 2027 or (ii) the date of the Issuer's 2027 annual meeting of stockholders.
Key Figures
Restricted stock units granted: 1,371 units
RSU vesting date: Earlier of June 10, 2027 or 2027 annual meeting
Stock options granted: 648 options
+5 more
8 metrics
Restricted stock units granted
1,371 units
Contingent right to one common share each; single vesting by 2027
RSU vesting date
Earlier of June 10, 2027 or 2027 annual meeting
Single annual installment vesting schedule
Stock options granted
648 options
Right to buy Praxis common stock
Option exercise price
$240.66 per share
Stock Option (Right to Buy) granted June 10, 2026
Option vesting schedule
12 equal monthly installments
From July 10, 2026 to earlier of June 10, 2027 or 2027 meeting
Option expiration date
June 10, 2036
Expiration of stock option right to buy 648 shares
Shares held after transactions
2,337 shares
Total Praxis common stock directly owned post-grant
Options held after transactions
648 options
Total stock options directly owned post-grant
Key Terms
restricted stock units, contingent right to receive one share, Stock Option (Right to Buy), vest in twelve (12) equal monthly installments, +1 more
5 terms
restricted stock units financial
"Ms. DeSimone was awarded 1,371 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) ... underlying security title: Common Stock"
vest in twelve (12) equal monthly installments financial
"The shares subject to this option shall vest in twelve (12) equal monthly installments occurring on the 10th day of each month"
annual meeting of stockholders financial
"the date of the Issuer's 2027 annual meeting of stockholders."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Praxis (PRAX) director Jill DeSimone report?
Jill DeSimone reported receiving equity compensation awards, not open-market trades. She was granted 1,371 restricted stock units and a stock option for 648 shares of Praxis common stock, both vesting over time based on specified dates tied to the company’s 2027 annual meeting.
How many Praxis (PRAX) restricted stock units were granted to Jill DeSimone?
She was granted 1,371 restricted stock units. Each unit represents a contingent right to receive one share of Praxis common stock, vesting in a single installment on the earlier of June 10, 2027 or the company’s 2027 annual meeting of stockholders, subject to continued service conditions.
What are the terms of Jill DeSimone’s new Praxis (PRAX) stock option?
She received a stock option covering 648 shares of Praxis common stock at an exercise price of $240.66 per share. The option vests in twelve equal monthly installments starting July 10, 2026 and ending on the earlier of June 10, 2027 or the 2027 annual stockholders meeting.
When do Jill DeSimone’s Praxis (PRAX) restricted stock units vest?
The 1,371 restricted stock units vest in a single annual installment on the earlier of June 10, 2027 or the date of Praxis’s 2027 annual meeting of stockholders. Settlement will occur only in shares of Praxis common stock according to the award terms described.
Are Jill DeSimone’s Praxis (PRAX) Form 4 transactions open-market purchases or sales?
The transactions are equity compensation awards, not market trades. The Form 4 shows grant-type acquisitions of 1,371 restricted stock units and a 648-share stock option, both awarded at a price of $0.00 per share as part of her director compensation package.
AI-generated analysis. How Rhea-AI works. Not financial advice.
